首页> 美国卫生研究院文献>other >Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities
【2h】

Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities

机译:发现具有δ/μ阿片样物质受体激动剂和神经激肽1受体拮抗剂活性的三肽衍生的多功能配体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several bifunctional peptides were synthesized and characterized based on the pentapeptide-derived ligand NP30 (>1: Tyr-DAla-Gly-Phe-Gly-Trp-O-[3’,5’-Bzl(CF3)2]). Modification and truncation of amino acid residues were performed, and the tripeptide-derived ligand NP66 (>11: Dmt-DAla-Trp-NH-[3',5'-(CF3)2-Bzl]) was obtained based on the overlapping pharmacophore concept. The Trp3 residue of ligand >11 works as a message residue for both opioid and NK1 activities. The significance lies in the observation that the approach of appropriate truncation of peptide sequence could lead to a tripeptide-derived chimeric ligand with effective binding and functional activities for both mu and delta opioid and NK1 receptors with agonist activities at mu and delta opioid and antagonist activity at NK1 receptors, respectively.
机译:基于五肽衍生的配体NP30(> 1 :Tyr-DAla-Gly-Phe-Gly-Trp-O- [3',5'-Bzl(CF3))合成并表征了几种双功能肽2])。进行氨基酸残基的修饰和截短,得到三肽衍生的配体NP66(> 11 :Dmt-DAla-Trp-NH- [3',5'-(CF3)2-Bzl])是基于重叠的药效团概念获得的。配体> 11 的Trp3残基充当阿片样物质和NK1活性的信息残基。意义在于观察到,适当截短肽序列的方法可能会导致三肽衍生的嵌合配体具有对mu和delta阿片样物质以及对mu和delta阿片样物质具有激动剂活性和拮抗剂活性的NK1受体有效的结合和功能活性分别在NK1受体上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号